Tenet Reports Strong Third Quarter 2024 Results; Raises 2024 Financial Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Wolfe Research Reiterates Outperform Rating on Tenet Healthcare (THC)
October 29, 2024 10:08 AM EDTWolfe Research analyst Justin Lake reiterated an Outperform rating and $178.00 price target on Tenet Healthcare (NYSE: THC).
The analyst comments "THC 3Q24 Beat on Strong SS Volume / Revenue Growth in Hospitals - THC reported 3Q24 rev of $5.12B, up 1.2% y/y ~1% above expectations. Adj. EBITDA of $978M up... More
